IE 11 is not supported. For an optimal experience visit our site on another browser.

Alphatec Spine to Present at the 2011 RBC Capital Markets Healthcare Conference

CARLSBAD, Calif., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced it will present in a fireside chat format at the 2011 RBC Capital Markets' Healthcare Conference on Wednesday, March 2, 2011 at 2:05 pm Eastern Time at The New York Palace Hotel in New York, New York.
/ Source: GlobeNewswire

CARLSBAD, Calif., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced it will present in a fireside chat format at the 2011 RBC Capital Markets' Healthcare Conference on Wednesday, March 2, 2011 at 2:05 pm Eastern Time at The New York Palace Hotel in New York, New York.

During such presentation, Michael O'Neill, Alphatec Spine's Chief Financial Officer, will provide an overview of the Company's activities. A live audio webcast of the presentation at the 2011 RBC Capital Markets' Healthcare Conference will be accessible through the Company's investor relations website at . An archived edition of the presentation will be available later that day and will be available for at least 30 days afterwards.

About Alphatec Spine

Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its subsidiary, Scient'x S.A.S., via a direct salesforce in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In Asia and Australia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc., and through Scient'x's distributors in China, Korea and Australia.  

The Alphatec Holdings, Inc. logo is available at

CONTACT: Michael O'Neill Chief Financial Officer Alphatec Spine, Inc. (760) 494-6746 investorrelations@alphatecspine.com Westwicke Partners Lynn C. Pieper (415) 202-5678 lynn.pieper@westwicke.com